FDA Inspection 1099461 — Katharina Blumchen, M.D.
The FDA completed an inspection of Katharina Blumchen, M.D. on July 18, 2019 in Frankfurt Am Main. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Frankfurt Am Main (Germany)
Additional Details
Clinical Investigator (CI)